Datavault AI Inc. (NASDAQ: DVLT) has announced a binding term sheet with Wellgistics Health (NASDAQ: WGRX) to form DelivMeds AI, a healthcare platform that integrates AI-driven pharmacy optimization, blockchain-enabled smart contracts, biometric verification, and direct-to-consumer healthcare delivery. The venture, valued at an expected approximate asset value of $4 billion subject to an independent fairness opinion, involves three concurrent transactions: an expanded PharmacyChain license, acquisition of QOLPOM intellectual property, and a controlling stake in Tollo Health. These transactions aim to support a national rollout of data-driven healthcare delivery and patient engagement solutions.
The collaboration leverages Datavault AI's expertise in AI-driven data experiences and valuation within the Web 3.0 environment. The company's cloud-based platform provides solutions in Acoustic Sciences and Data Science divisions, including WiSA, ADIO, and Sumerian technologies for spatial audio, and data perception, valuation, and monetization tools. Wellgistics Health brings its pharmacy and healthcare logistics capabilities to the partnership.
DelivMeds AI is positioned to transform healthcare delivery by using AI to optimize pharmacy operations, blockchain for secure smart contracts, and biometric verification to ensure patient identity. The direct-to-consumer model aims to streamline access to medications and health services. The $4 billion valuation underscores the scale of the initiative, which is expected to roll out nationally once the fairness opinion is completed.
Datavault AI, headquartered in Philadelphia, PA, is publicly traded on NASDAQ under the ticker DVLT. The company's technology suite includes AI- and machine-learning-based automation, third-party integration, and analytics, serving industries such as sports, entertainment, biotech, fintech, real estate, healthcare, and energy. For more information, visit www.dvlt.ai.
The press release detailing the announcement is available at https://ibn.fm/yIVh9. Additional news and updates relating to DVLT are accessible in the company's newsroom at https://ibn.fm/DVLT.
